EGFR and triple-negative breast carcinoma: Polycefin nano drug variants were also engineered to treat human Epidermal Growth Factor Receptor (EGFR)-positive lung cancer, triple negative breast cancer, and HER-2/neu positive breast tumors in nude mice.